Vivani Medical is trading 5.3% up at $1.40 amid a broad risk-on rally in U.S. equities and strength in biotech peers.

  • The move aligns with macro momentum as the S&P 500 and Nasdaq both jumped approximately 2%.
  • The biotech sector is seeing significant strength, with the XBI ETF rising over 2%.
  • The stock appears to be moving in line with sector trends rather than any fresh company-specific catalysts or news headlines today.